Pneumococcal vaccines and long-term protection

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Pneumococcal disease is one of the biggest killers of children under 5 years of age worldwide, mostly in developing countries. Pneumococcal conjugate vaccines are highly effective at reducing pneumococcal disease however the duration of protection and the immune factors involved is unknown, particularly when fewer than the recommended number of doses are used. My fellowship aims to examine the key immune factors that provide long-term protection following pneumococcal vaccination.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2021

Funding Scheme: Career Development Fellowships

Funding Amount: $483,402.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

immunology | paediatric | pneumococcal vaccination | protection | vaccine-preventable diseases